Antipodes Partners LTD 908 Devices Inc. Transaction History
Antipodes Partners LTD
- $3.16 Billion
- Q1 2025
A detailed history of Antipodes Partners LTD transactions in 908 Devices Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 4,382 shares of MASS stock, worth $29,315. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,382Holding current value
$29,315% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MASS
# of Institutions
94Shares Held
20.8MCall Options Held
51.3KPut Options Held
92.8K-
Awm Investment Company, Inc. New York, NY5.2MShares$34.8 Million3.72% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.9MShares$19.4 Million0.14% of portfolio
-
First Light Asset Management, LLC Edina, MN1.7MShares$11.4 Million0.98% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$11.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.36MShares$9.11 Million0.0% of portfolio
About 908 Devices Inc.
- Ticker MASS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,590,200
- Market Cap $211M
- Description
- 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...